The clinical profiles of ll Japanese patients with recurrent episodes of Guillain-Barre syndrome (GBS), including 3 of our cases out ofa total of76 patients (48 males and 28 females), are reviewed. The recurrence rate was estimated as 4 %. Among the ll Japanese patients, 10 were male. Various viral infections had been confirmed in 1 case. No patients showed recurrent ophthalmoplegia. Sensory involvement varied from one episode to the next. These findings suggest the changing distribution of the demyelinating lesions and possibly a different reaction to the unknown pathogens in the recurrence of GBS. (Internal
Introduction
Guillain-Barre syndrome (GBS) may recur. In several large series of Caucasian cases the recurrence rate was estimated to be 1 to 10% of GBS patients after complete recovery (1) . In Japan, there is no detailed analysis of recurrent GBS as it has rarely been reported in the Japanese literature. Recognition of recurrent GBS is important, because relapse is common in another group of idiopathic acquired neuropathies, chronic inflammatory demyelinating polyneuropathy (CIDP) (2) . Here we describe 3 of our cases, who were among 76 patients with GBS; we further summarize the clinical features of 1 1 patients with recurrent GBS reported in the Japanese literature.
Patients and Methods
Recurrent GBS was defined as 2 or more episodes of acute inflammatory demyelinating polyneuropathy (AIDP) , each with an onset phase lasting less than 4 weeks or less followed by complete or nearly-complete recovery. From a chart review of 76 patients (48 males and 28 females) diagnosed as GBS between January 1972 and December 1993, 3 cases confirming to the above criteria of recurrent GBS were compiled from the neurological departments affiliated with the Department of Neurology of Hirosaki University. To determine the number of Japanese cases with recurrent GBS, we first searched for case reports of recurrent GBS and CIDP from the prominent neurological Japanese journals published after 1973: Clinical Neurology (Tokyo), Neurological Medicine (Tokyo), No to Hattatsu (Brain and Development), andAto to Shinkei (Brain and Nerve). We also searchedNeurology, Archives of Neurology, Annals of Neurology, Journal of Neurology, Neurosurgery and Psychiatry, Journal of Neurology after 1973, to find any published Japanese cases. We referred to Index Medicus and Igaku Chuou Zasshi to collect more cases. The cases with an onset progressive phase lasting more than four weeks, after the diagnostic criteria of GBS (3) and CIDP (4) were excluded. Cases with Miller-Fisher syndrome, and those showing clouding of consciousness during the early phase of weakness were also excluded. Functional grade (FG) was estimated after the score using the following scale: 0 = healthy; 1 = minor symptoms or signs and not limited in ordinary daily work; 2 = able to walk 5 m without assistance but unable to do physical work; 3 = able to walk 5 m with assistance only; 4 = chair-or bed-bound; 5 = assisted ventilation required.
Case Reports

Patient 1
In May 1971, this 34-year-old male felt numbness in the distal lower extremities. He had no preceding infectious illness. Two days later all limbs became weak. He was bed-ridden within a week. FG was estimated as 4. There was neither ocular, facial, nor respiratory involvements. Distal sensation was slightly diminished. His weakness and sensory loss fully recovered within 6 months. At age 44 he noticed tingling sensation in the limbs again. Since difficulty in walking progressed in a few days, he was admitted to a hospital. He was then bed ridden for one month due to severe quadriparesis. FG was 4. He had no double vision. Cerebrospinal fluid (CSF) protein was 58 mg/dl, and there was no abnormal pleocytosis. The weakness finally recovered fully several months later. In 1986, at age 48, he was aware of numbness in the legs which was followed by difficulty in walking, again. He developed double vision. When he was admitted to a hospital, FG was 4. Deep sensation was severely lost distally. Plantar responses were flexor. CSF protein was 45 mg/dl initially, then elevated to 218 mg/dl 2 weeks later. Motor nerve conduction studies of the right median nerve revealed prolonged distal latency, dispersed compound motor potential, and a fall in conduction velocity. Two months later his weakness started to improve. Six months after the onset, deep sensation was restored, and his FG was 1. No recurrence has been reported for the recent 8 years.
Patient 2
In 1965, a 23-year-old man developed acute weakness and numbness in the four extremities, a few weeks after a flu-like illness. He was admitted to a hospital, when walking difficulty developed. FG was estimated as 3. He had normal vision. One month later the weakness started to improve, and he finally recovered completely with a 4-month course. In August 1975, at age 33, a few days after diarrhea, he was aware of numbness in his hands, then weakness developed in his extremities. When he was referred to us, he had mild facial weakness, quadriplegia of FG 4, areflexia, and normal sensation. CSF protein was 53 mg/dl initially, and 76 mg/dl a month later. Right ulnar motor conduction study revealed a fall in amplitude and a delay of distal latency. Conduction velocity was normal. In the right posterior tibial nerve, a reduced conduction velocity and a prolonged distal latency were confirmed. He then showed rapid spontaneous recovery in the second month. He reobtained almost normal power 3 months later. He has had no recurrence for 10 years.
Patient 3
In 1960 at age ll a boy developed weakness in the lower extremities and was admitted to a pediatric clinic, where diagnosis ofGBS was made. Maximum FG was estimated as 3. He recovered without any residuals after a 6-month course. He was completely healthy until October 1974, at the age of 26, when he developed diplopia and difficulty in gait acutely. He had had flu a week before. He had mild ophthalmoplegia, severe quadriparesis, distal sensory loss, and areflexia, when he was admitted on day 7. The FG was 4. CSFprotein was 33 mg/dl on day 7, and 63 mg/dl 3 weeks later. F-wave population was diminished and the minimal F latency was delayed to more than 30 msec inthe arms and 60 msec in the legs. His muscle strength recovered to normal during a five-month course. No recurrence has been noticed for 15 years.
Clinical Profiles of the Japanese Cases
We examined the data of 8 convincing cases with recurrent GBS (5-12) meeting the above criteria from the Japanese Ophthalmoplegia and sensory involvement: Four cases had external ophthalmoplegia either in the initial or in recurrent episodes. There was no case with recurrent ophthalmoplegia. Sensory deficits were found in 5 cases, one of which was r ecurrent (case 9).
CSFfindings: CSF examination was carried out in 17 episodes. There was no increase in number of cells in the episodes. CSF protein level of 50 mg/dl or more was recorded in 13 episodes. In 13 repeated examinations of CSF, protein content was higher in the second examination performed during or after the peak of illness.
Discussion
Three patients with recurrent GBS presented here was estimated as about 4% of total 76 cases with GBS under our care. In several large series of Caucasian patients, 1 to 10% recovered completely and had acute recurrences several months to decades later (1 (2, 4) . Progression of weakness ofCIDP typically lasts more than eight weeks, far slower than GBS, however, some "intermediate" cases whose peak of weakness is found between 1 to 2 months have sometimes been reported (14). For this point, CSF protein is often diagnostic to distinguish recurrent GBS from relapsing CIDP, since CSF proteinjust after the onset of weakness is often normal or at least lowerthan the value of few weeks later in a recurrence of GBS, while CIDP may show a high CSF protein level even in an early phase of its relapse.
As the pathogenesis of acute recurrence, a smoldering persistent inflammation in the nerves is suspected, because similar symptoms and signs with each episode were seen in a autopsied case reported by Asbury et al ( 15). However, facts that ophthalmoplegia was never recurrent and that sensory involvement varied from one episode to another definitely go against the persistent inflammation hypothesis.
The changing distribution of weakness was pointed out by Grand 10:1 of the present series. In general, males are slightly more susceptible to GBS; in fact, the male:female ratio of the present total 76 cases was 1.7:1, which is similar to many major reported series of GBS (1) . The patients with recurrent GBS reported by Grand'Maison et al (13) consisted of7 males and 5 females. The reason or the cause for the male preponderance in the present series is not clear. Genetic factors might play a role, however, there is also possibility of more unreported cases elsewhere. Further studies with a larger population will be necessary to confirm this peculiar male predominancy.
